Antagonists and inhibitorsMeSH Qualifier

https://ansm.sante.fr/actualites/medicaments-hypocholesterolemiants-anti-pcsk9-la-prescription-elargie-aux-medecins-vasculaires-et-aux-neurologues
2022
false
false
false
France
French
drug information
drug prescriptions
anticholesteremic agents
PCSK9 protein, human
hypercholesterolemia
mixed dyslipidemia
Homozygous Familial Hypercholesterolemia
atherosclerosis
alirocumab
alirocumab
evolocumab
evolocumab
injections, subcutaneous

---
https://www.has-sante.fr/jcms/p_3322781/fr/koselugo-selumetinib
2022
false
false
false
France
selumetinib
treatment outcome
insurance, health, reimbursement
Mitogen-Activated Protein Kinase Kinase Inhibitor
MAPK-ERK kinases
child
Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas
neurofibroma, plexiform
neurofibromatosis 1
protein kinase inhibitors
protein kinase inhibitors
administration, oral
selumetinib
evaluation of the transparency committee
selumetinib

---
https://www.cochrane.org/fr/CD007929/GYNAECA_les-inhibiteurs-de-la-parp-ameliorent-ils-la-survie-des-femmes-atteintes-dun-cancer-de-lovaire-et
2022
false
true
false
France
United Kingdom
dna repair enzymes
treatment outcome
review of literature
french abstract
ovarian neoplasms

---
https://www.cbip.be/fr/articles/3677?folia=3674
2021
false
false
false
Belgium
French
journal article
neoplasms
Interleukin Inhibitor
interleukins
Long Term Adverse Effects

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/COVID-19/Outil_clinique_Usage-Tocilizumab-Sarilumab.pdf
2021
false
false
true
Canada
French
Interleukin-6
quebec
tocilizumab
tocilizumab
sarilumab
sarilumab
treatment outcome
drug therapy, combination
glucocorticoids
adult
aged
Interleukin 6 receptor antagonist (disposition)
guidelines for drug use
receptors, interleukin-6
biological therapy
pneumonia, viral
coronavirus infections
antibodies, monoclonal, humanized
pandemics
COVID-19

---
https://www.cochrane.org/fr/CD003424/CF_medicaments-destines-reduire-lacidite-gastrique-chez-les-personnes-atteintes-de-mucoviscidose
2021
false
United Kingdom
France
French
review of literature
cystic fibrosis
treatment outcome
gastric acidity, nos
gastric acid
gastrointestinal agents
histamine h2 antagonists
proton pumps
french abstract

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/COVID-19/COVID-19_INESSS_biotherapie_IL-1.pdf
2020
false
false
true
Canada
pneumonia, viral
coronavirus infections
Interleukin-6
quebec
siltuximab
siltuximab
tocilizumab
tocilizumab
sarilumab
sarilumab
treatment outcome
guideline
receptors, interleukin-6
biological therapy
interleukin-6
pneumonia, viral
coronavirus infections
pandemics
antibodies, monoclonal
antibodies, monoclonal, humanized
COVID-19

---
http://www.senat.fr/notice-rapport/2019/r19-345-notice.html
2020
false
false
false
France
fungicides, industrial
succinate dehydrogenase inhibitors
succinate dehydrogenase inhibitors
risk assessment
technical report
antifungal agents
fungicide, nos
succinate dehydrogenase

---
https://www.ssmg.be/wp-content/uploads/RMG/371/RMG371_06-15.pdf
2020
false
false
false
Belgium
deep vein thrombosis
fibrin fragment D
risk factors
Wells deep vein thrombosis clinical probability score (observable entity)
deep vein thrombosis
Doppler ultrasonography of venous structure (procedure)
ultrasonography, doppler
anticoagulants
heparin, low-molecular-weight
antivitamins K
Factor Xa Inhibitors
antithrombins
Duration of treatment (qualifier value)
time
journal article
patient care management
deep vein thrombosis
venous thrombosis
lower extremity
venous thrombosis
venous thrombosis
venous thrombosis
fibrin fibrinogen degradation products
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/biotherapies-ciblant-la-voie-de-linterleukine-1.html
2020
false
false
false
Canada
pneumonia, viral
coronavirus infections
Interleukin-1
anakinra
canakinumab
guideline
biological therapy
interleukin 1 receptor antagonist protein
pandemics
pneumonia, viral
coronavirus infections
pandemics
antibodies, monoclonal
COVID-19

---
https://www.cochrane.org/fr/CD011748/VASC_inhibiteurs-de-la-pcsk9-pour-la-prevention-des-maladies-cardiovasculaires
2020
false
false
false
France
United Kingdom
Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action (substance)
Proprotein Convertase 9
treatment outcome
Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action (substance)
cholesterol, LDL
alirocumab
evolocumab
Evidence-Based medicine
review of literature
french abstract
cardiovascular diseases
cardiovascular prevention
antibodies, monoclonal

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/anticoagulants-oraux-directs-et-warfarine-dans-la-fibrillation-auriculaire-et-la-thromboembolie-veineuse.html
2019
false
false
false
Canada
administration, oral
Direct acting anticoagulant (substance)
quebec
adult
deep vein thrombosis
pulmonary embolism
Factor Xa Inhibitors
antithrombins
antivitamins K
practice guideline
technical report
oral anticoagulants
atrial fibrillation
venous thromboembolism
warfarin
anticoagulants
venous thrombosis
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1265
2019
false
false
false
false
France
comparative effectiveness research
treatment outcome
EGFR Gene Mutation
protein kinase inhibitors
protein-tyrosine kinases
antineoplastic agents
Gefitinib
Afatinib
clinical trials, phase iii as topic
antineoplastic agents
protein kinase inhibitors
lung neoplasms
lung neoplasms
carcinoma, non-small-cell lung
osimertinib
osimertinib
Tyrosine Kinase Inhibitors
critical appraisal or critical reading
carcinoma, non-small-cell lung
piperazines
piperazines
acrylamides
aniline compounds
acrylamides
aniline compounds

---
https://www.louvainmedical.be/fr/article/anticoagulants-oraux-directs-comment-choisir
2019
false
false
false
Belgium
atrial fibrillation
anticoagulants
administration, oral
antithrombins
Factor Xa Inhibitors
stroke
antivitamins K
journal article
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
https://www.cosprc.ca/fr/sustained-funding-to-ensure-access-to-anti-vascular-endothelial-growth-factor-drugs-2019/
2019
false
false
false
false
Canada
drug costs
wet macular degeneration
wet macular degeneration
Ranibizumab
Ranibizumab
aflibercept
aflibercept
Bevacizumab
Bevacizumab
macular edema
diabetic retinopathy
wet macular degeneration
insurance, health, reimbursement
canada
retinal diseases
guidelines
VEGF inhibitors
vascular endothelial growth factors
recombinant fusion proteins
receptors, vascular endothelial growth factor
recombinant fusion proteins
receptors, vascular endothelial growth factor

---
https://www.cochrane.org/fr/CD012448/les-inhibiteurs-du-tnf-compares-au-placebo-ou-en-association-chez-les-enfants-atteints-de-la-maladie
2019
false
false
false
France
United Kingdom
Tumor necrosis factor alpha (TNF-α) inhibitors
mucocutaneous lymph node syndrome
treatment outcome
review of literature
french abstract
mucocutaneous lymph node syndrome
child
placebos
tumor necrosis factor-alpha
Tumor Necrosis Factor Inhibitors

---
https://www.cochrane.org/fr/CD005139/agents-anti-facteur-de-croissance-de-lendothelium-vasculaire-pour-la-degenerescence-maculaire
2019
false
false
false
France
United Kingdom
treatment outcome
Bevacizumab
Ranibizumab
pegaptanib
comparative effectiveness research
ocular vascular disorder agents
review of literature
french abstract
macular degeneration
vascular endothelial growth factor a
aptamers, nucleotide

---
https://www.cochrane.org/fr/CD012577/medicament-anti-facteur-de-necrose-tumorale-pour-le-traitement-dun-gonflement-larriere-de-loeil
2019
false
false
false
France
United Kingdom
macular edema
treatment outcome
review of literature
french abstract
macular edema
uveitis
tumor necrosis factors
Tumor Necrosis Factor Inhibitors

---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-VEGFR-axitinib-cabozantinib-pazopanib-sorafenib-sunitinib
2019
false
false
false
France
Axitinib
cabozantinib
pazopanib
Sorafenib
Sunitinib
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
risk factors
patient education as topic
continuity of patient care
administration, oral
receptors, vascular endothelial growth factor
carcinoma, renal cell
drug interactions
pregnancy
Tyrosine Kinase Inhibitors
guidelines for drug use
Sorafenib
pazopanib
Axitinib
Sunitinib
cabozantinib
pyrimidines
sulfonamides
anilides
pyridines
pyrimidines
sulfonamides
anilides
pyridines
anilides
pyridines
pyrimidines
sulfonamides

---
https://www.snfge.org/content/cp032-anti-tnfa-bilan-initial-et-suivi
2019
false
false
false
France
continuity of patient care
Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance)
pregnancy
latent tuberculosis
withdrawing treatment
surgical procedures, operative
scientific and technical information
tumor necrosis factor-alpha
withholding treatment
Tumor Necrosis Factor Inhibitors

---
http://www.cochrane.org/fr/CD008980/les-inhibiteurs-du-facteur-xa-compares-aux-antagonistes-de-la-vitamine-k-pour-la-prevention-de
2018
false
false
United Kingdom
France
French
review of literature
french abstract
thromboembolism
vitamin K
atrial fibrillation
antithrombin III
antifibrinolytic agents
treatment outcome

---
https://www.has-sante.fr/portail/jcms/c_1252051/fr/prevention-vasculaire-apres-un-infarctus-cerebral-ou-un-accident-ischemique-transitoire
2018
false
true
true
false
France
French
practice guideline
cerebral infarction
ischemic attack, transient
stroke
myocardial infarction
adult
hypertension
antihypertensive agents
dyslipidemias
hydroxymethylglutaryl-coa reductase inhibitors
diabetes mellitus
smoking
alcohol drinking
obesity
hyperhomocysteinemia
atrial fibrillation
vitamin K
anticoagulants
foramen ovale, patent
fibrinolytic agents
heart valve prosthesis
heart valve diseases
platelet aggregation inhibitors
carotid stenosis
endarterectomy, carotid
vertebral artery dissection
anticoagulotherapy

---
http://www.thromboclic.fr/
2018
false
false
false
false
France
French
anticoagulants
clinical tool
practice guideline
guidelines for drug use
patients guideline
vitamin K
administration, oral
decision support systems, clinical
antithrombins
deep vein thrombosis
recurrence
atrial fibrillation
pulmonary embolism
venous thrombosis

---
https://www.ameli.fr/sites/default/files/Documents/5461/document/traitement-avk-accompagnement-pharmacien_assurance-maladie.pdf
2018
false
false
false
false
France
French
patient education handout
forms
anticoagulants
anticoagulotherapy
pharmacists
antivitamins K
indenes
4-hydroxycoumarins
vitamin K

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=652
2018
false
false
false
France
French
public health guidelines
influenza, human
antiviral agents
neuraminidase

---
https://www.revmed.ch/RMS/2017/RMS-N-565/Acidocetose-euglycemique-une-complication-des-inhibiteurs-du-SGLT2
2018
false
false
false
Switzerland
French
administration, oral
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Product containing sodium glucose cotransporter subtype 2 inhibitor (product)
SGLT2 Inhibitor
Sodium-Glucose transporter 2
Canagliflozin
hypoglycemic agents
empagliflozin
dapagliflozin
ketosis
journal article
practice guidelines as topic
precipitating factors
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
benzhydryl compounds
glucosides

---
https://www.revmed.ch/RMS/2017/RMS-N-565/Association-des-analogues-du-GLP-1-et-des-inhibiteurs-du-SGLT2-de-nouvelles-perspectives
2018
false
false
false
Switzerland
French
journal article
administration, oral
hypoglycemic agents
diabetes mellitus, type 2
switzerland
treatment outcome
body weight
cardiovascular diseases
drug therapy, combination
GLP-1 Mimetics
glucagon-like peptide 1
Glucagon-like peptide-1 (GLP-1) analogues
SGLT2 Inhibitor
Sodium-Glucose transporter 2
dulaglutide
Liraglutide
empagliflozin
dapagliflozin
Canagliflozin
blood glucose
arterial pressure
genetic pleiotropy
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
peptides
venoms
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
glucagon-like peptides
benzhydryl compounds
glucosides
Exenatide

---
https://www.has-sante.fr/portail/jcms/c_2851086/fr/les-anticoagulants-oraux
2018
false
false
false
France
French
guidelines for drug use
anticoagulants
anticoagulants
administration, oral
antivitamins K
antivitamins K
atrial fibrillation
drug overdose
apixaban
Dabigatran
antithrombins
Factor Xa Inhibitors
Rivaroxaban
edoxaban
Direct factor Xa inhibitors
direct thrombin inhibitors
pregnancy
patient compliance
continuity of patient care
hemorrhage
surgical procedures, operative
blood loss, surgical
hemorrhage
vitamin k antagonists
fluindione
acenocoumarol
warfarin
pyridines
thiazoles
phenindione
phenindione
indenes
4-hydroxycoumarins
vitamin K
vitamin K
indenes
4-hydroxycoumarins
vitamin K
pyrazoles
pyridones

---
http://www.reseau-naissance.fr/medias/2018/07/Referentiel_anticoag_accouchement_RSN_2018VF-1.pdf
2018
false
false
false
France
French
anticoagulants
anticoagulants
guidelines for drug use
pregnancy
heparin
heparin
thromboembolism
heart valve prosthesis
continuity of patient care
vitamin K
antivitamins K
parturition
injections, subcutaneous
injections, intravenous
administration, oral
anesthesia, epidural
indenes
4-hydroxycoumarins

---
https://www.revmed.ch/RMS/2017/RMS-N-571/Inhibiteur-de-la-DPP-4-ou-des-SGLT2-apres-echec-de-la-metformine-seule-dans-le-diabete-de-type-2
2018
false
false
false
Switzerland
French
journal article
dipeptidyl-peptidase iv inhibitors
Sodium-Glucose transporter 2
SGLT2 Inhibitor
diabetes mellitus, type 2
metformin
treatment outcome
drug therapy, combination
dipeptidyl peptidase 4 (DPP-4) inhibitors
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Sodium-Glucose Transporter 2 Inhibitors

---
https://www.snfge.org/download/file/fid/68
2018
false
false
false
France
Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance)
Contraindications, Drug
vaccination
vaccines
guideline
inflammatory bowel diseases
anti-TNF
tumor necrosis factor-alpha
Tumor Necrosis Factor Inhibitors

---
http://www.sfendocrino.org/_images/mediatheque/articles/pdf/recommandations/2018_Immunotherapies%20/mced_94_bd.pdf
2018
false
false
false
France
French
immunotherapy
antibodies, monoclonal
consensus
continuity of patient care
Tyrosine Kinase Inhibitor
protein-tyrosine kinases
protein kinase inhibitors
TOR Serine-Threonine kinases
adrenal glands
pituitary gland
metabolism
endocrine system diseases
diabetes mellitus
Hypophysitis
hypothyroidism
adrenal insufficiency
Hormone Measurement
hormones
Tyrosine Kinase Inhibitors

---
https://ansm.sante.fr/informations-de-securite/Traitement-par-antivitamines-K-AVK-nouvelles-informations
2018
false
false
false
France
French
pregnancy
Contraindications, Drug
fluindione
antivitamins K
anticoagulants
guidelines for drug use
pharmacovigilance note
drug hypersensitivity
abortion, spontaneous
abnormalities, drug-induced
fluindione
anticoagulants
warfarin
acenocoumarol
phenindione
phenindione
indenes
4-hydroxycoumarins
vitamin K
vitamin K
phenindione

---
https://cps.ca/fr/documents/position/les-antiviraux-contre-la-grippe-des-conseils-aux-praticiens
2018
false
false
false
Canada
risk factors
algorithms
neuraminidase inhibitors
neuraminidase
infant
child
adolescent
oseltamivir
zanamivir
practice guideline
influenza, human
antiviral agents

---
Summary Safety Review - Vascular endothelial growth factor receptor tyrosine kinase inhibitors
https://hpr-rps.hres.ca/reg-content/resume-examen-innocuite-detail.php?lang=fr&linkID=SSR00213
2018
false
false
false
Canada
French
English
receptors, vascular endothelial growth factor
protein kinase inhibitors
soft tissue neoplasms
kidney neoplasms
liver neoplasms
arteries
aneurysm
Aortic Dissection
aorta
pazopanib
ponatinib
regorafenib
vandetanib
lenvatinib
administration, oral
risk assessment
pharmacovigilance note
Tyrosine Kinase Inhibitors
indoles
pyrroles
phenylurea compounds
niacinamide
niacinamide
imidazoles
indazoles
pyrimidines
sulfonamides
pyridazines
pyridines
piperidines
quinazolines
quinolines
Sorafenib
Sunitinib
Axitinib

---
https://www.cochrane.org/fr/CD008170/inhibiteurs-du-systeme-renine-angiotensine-par-rapport-dautres-types-de-medicaments-contre
2018
false
false
false
France
United Kingdom
angiotensin-converting enzyme inhibitors
comparative effectiveness research
treatment outcome
angiotensin receptor antagonists
antihypertensive agents
renin
review of literature
french abstract
renin inhibitors
hypertension
renin-angiotensin system

---
https://www.urofrance.org/sites/default/files/fileadmin/medias/afu/comites/cpp/travaux/20181018-ei_parcours_de_soins_prostate-synthese-version_finale.pdf
2018
false
false
true
France
antineoplastic agents, hormonal
androgen antagonists
gonadotropin-releasing hormone
androgen antagonists
heart
musculoskeletal system
fatigue
anxiety
depression
cognition disorders
gynecomastia
hot flashes
infertility, male
sexual and gender disorders
pain
quality of life
guideline
prostatic neoplasms
patient care management

---
https://pharmacomedicale.org/medicaments/par-specialites/item/medicaments-de-la-dmla
2018
false
true
false
France
intravitreal injections
Ranibizumab
Bevacizumab
aflibercept
receptors, vascular endothelial growth factor
vascular endothelial growth factors
angiogenesis inhibitors
Tyrosine Kinase Inhibitors
drug information
wet macular degeneration
recombinant fusion proteins
receptors, vascular endothelial growth factor

---
https://pharmacomedicale.org/medicaments/par-specialites/item/medicaments-du-systeme-renine-angiotensine
2018
false
true
false
France
angiotensin-converting enzyme inhibitors
angiotensin II type 1 receptor blockers
renin inhibitors
renin
drug information
renin-angiotensin system

---
https://pharmacomedicale.org/medicaments/par-specialites/item/traitements-de-l-anemie-les-points-essentiels-2
2018
false
true
false
France
neprilysin
angiotensin II receptor antagonists
sacubitril and valsartan sodium hydrate drug combination
sacubitril and valsartan sodium hydrate drug combination
sacubitril and valsartan sodium hydrate drug combination
valsartan and sacubitril
heart failure
sacubitril
Valsartan
drug information
angiotensin receptor antagonists
sacubitril and valsartan sodium hydrate drug combination
sacubitril and valsartan sodium hydrate drug combination
sacubitril and valsartan sodium hydrate drug combination
aminobutyrates
tetrazoles
aminobutyrates
tetrazoles
aminobutyrates
tetrazoles

---
https://www.has-sante.fr/jcms/c_2806295/fr/ilaris-canakinumab-inhibiteur-de-l-interleukine-1
2018
false
true
false
France
guidelines for drug use
adult
adolescent
child
insurance, health, reimbursement
treatment outcome
periodic fever, familial, autosomal dominant
hyperimmunoglobulinemia D
familial mediterranean fever
injections, subcutaneous
canakinumab
evaluation of the transparency committee
interleukin inhibitors
Interleukin-1beta
canakinumab
mevalonate kinase deficiency
antibodies, monoclonal
fever
hereditary autoinflammatory diseases

---
https://rmlg.uliege.be/article/2974
2018
false
false
false
false
Belgium
French
journal article
diabetes mellitus, type 2
cardiovascular diseases
hypoglycemic agents
empagliflozin
treatment outcome
empagliflozin
Sodium-Glucose transporter 2
comparative effectiveness research
Liraglutide
liraglutide
Glucagon-Like Peptide-1 Receptor
incretins
case reports
prognosis
cardiovascular diseases
drug therapy, combination
diabetes mellitus, type 2
renal insufficiency, chronic
belgium
insurance, health, reimbursement
Clinical Decision-Making
risk factors
Sodium-Glucose Transporter 2 Inhibitors
benzhydryl compounds
glucosides

---
https://dumas.ccsd.cnrs.fr/dumas-01464736
2017
false
true
false
France
French
dissertations, academic
vitamin K
international normalized ratio

---
https://dumas.ccsd.cnrs.fr/view/index/docid/1511631
2017
false
true
false
France
French
dissertations, academic
general practice
patient education as topic
general practitioners
physician's role
vitamin K

---
https://www.has-sante.fr/portail/jcms/c_2800955/fr/place-dans-la-strategie-therapeutique-de-lucentis-eylea-et-de-leurs-comparateurs-cliniquement-pertinents-dans-la-forme-neovasculaire-humide-de-la-dmla
2017
false
false
false
France
French
evaluation of the transparency committee
intravitreal injections
wet macular degeneration
comparative effectiveness research
vascular endothelial growth factor a
Ranibizumab
ranibizumab
treatment outcome
aflibercept
aflibercept
Bevacizumab
angiogenesis inhibitors
risk management
receptors, vascular endothelial growth factor
recombinant fusion proteins

---
http://www.sudoc.fr/219806373
2017
false
true
false
France
French
dissertations, academic
aged
anticoagulants
inpatients
vitamin K

---
https://www.jle.com/fr/revues/jpc/e-docs/anticoagulants_chez_les_patients_fragiles_sept_situations_a_risque_310985/article.phtml
10.1684/jpc.2017.0369
2017
false
false
false
France
French
journal article
anticoagulants
anticoagulants
risk management
pregnancy
breast feeding
neoplasms
venous thromboembolism
venous thromboembolism
risk factors
renal insufficiency, chronic
underweight
malnutrition
polypharmacy
cognition disorders
accidental falls
hemorrhage
continuity of patient care
medication adherence
frail elderly
adult
administration, oral
aged
Direct acting anticoagulant (substance)
antivitamins K
heparin, low-molecular-weight
Factor Xa Inhibitors
practice guidelines as topic
injections
Anticoagulant adverse reaction (disorder)
thinness
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
http://www.sudoc.fr/199232962
2017
false
false
false
France
French
dissertations, academic
persons
punctures
aged
aged, 80 and over
Pilots
persons
capillaries
punctures
aged
international normalized ratio
blood specimen collection
Pilots
data collection
pilot projects
residential facilities
vitamin K
aged, 80 and over
evaluation studies as topic

---
http://kce.fgov.be/fr/publication/report/anticoagulation-et-fibrillation-auriculaire
2017
false
false
false
Belgium
French
anticoagulants
anticoagulants
atrial fibrillation
treatment outcome
stroke
continuity of patient care
Cost-Benefit analysis
medication adherence
risk assessment
hemorrhage
vitamin K
antivitamins K
Rivaroxaban
edoxaban
Dabigatran
apixaban
Factor Xa Inhibitors
antithrombins
belgium
technical report
drug information
comparative study
anticoagulants
economic evaluation
drug monitoring
new oral anticoagulant
indenes
4-hydroxycoumarins
pyridines
thiazoles
pyrazoles
pyridones

---
https://www.revmed.ch/RMS/2017/RMS-N-552/ARNI-nouvelle-abreviation-pour-un-nouveau-traitement-de-l-insuffisance-cardiaque
2017
false
false
false
Switzerland
French
heart failure
angiotensin receptor antagonists
neprilysin
sacubitril and valsartan sodium hydrate drug combination
valsartan and sacubitril
treatment outcome
Left ventricular failure
journal article
algorithms
heart failure
Left ventricular ejection fraction (observable entity)
drug combinations
Renin-Angiotensin-Aldosterone system
natriuretic peptides
renin-angiotensin system
aminobutyrates
tetrazoles

---
https://www.revmed.ch/RMS/2017/RMS-N-558/Inhibiteurs-de-la-PCSK9
2017
false
false
false
Switzerland
French
journal article
Proprotein Convertase 9
Proprotein Convertase 9
anticholesteremic agents
anticholesteremic agents
cardiovascular diseases
risk factors
cholesterol, LDL
At increased risk for cardiovascular event (finding)
hydroxymethylglutaryl-coa reductase inhibitors
hypercholesterolemia
Proprotein Convertase 9
mutation
alirocumab
evolocumab
PCSK9 protein, human
bococizumab
comparative effectiveness research
high serum cholesterol, familial
antibodies, monoclonal
serine endopeptidases
proprotein convertases
antibodies, monoclonal, humanized
hyperlipoproteinemia type ii

---
https://www.revmed.ch/RMS/2017/RMS-N-571/Options-therapeutiques-chez-un-patient-diabetique-de-type-2-mal-controle-par-une-insuline-basale
2017
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
administration, oral
insulin
injections, subcutaneous
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
SGLT2 Inhibitor
Sodium-Glucose transporter 2
drug therapy, combination
Glucagon-Like Peptide-1 Receptor
drug combinations
Sodium-Glucose Transporter 2 Inhibitors

---
http://www.cochrane.org/fr/CD002001/les-antagonistes-de-la-vitamine-k-ou-lheparine-de-bas-poids-moleculaire-pour-le-traitement-long
2017
false
United Kingdom
France
French
anticoagulotherapy
meta-analysis
vitamin K
heparin, low-molecular-weight
anticoagulants
fibrinolytic agents
venous thromboembolism
treatment outcome
french abstract

---
http://www.cochrane.org/fr/CD002021
2017
false
true
false
United Kingdom
France
analgesics, opioid
opioid-related disorders
treatment outcome
conscious sedation
Opioid withdrawal
review of literature
french abstract

---
https://dumas.ccsd.cnrs.fr/dumas-01685156
2017
false
true
false
France
French
dissertations, academic
health literacy
anticoagulants
vitamin K

---
https://pharmacomedicale.org/medicaments/par-specialites/item/inhibiteurs-de-la-synthese-des-facteurs-vitamine-k-dependants-avk
2016
false
false
false
France
French
antivitamins K
drug information
anticoagulants
vitamin K
antivitamins K
vitamin k, nos
indenes
4-hydroxycoumarins
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
http://dune.univ-angers.fr/documents/dune5610
2016
false
true
false
France
French
dissertations, academic
health literacy
patient medication knowledge
antivitamins K
anticoagulants
vitamin K

---
https://www.revmed.ch/RMS/2016/RMS-N-542/Anticoagulants-oraux-directs-ACOD-une-aide-a-la-prescription-dans-la-pratique-quotidienne
2016
false
false
false
Switzerland
French
journal article
venous thromboembolism
antithrombins
administration, oral
atrial fibrillation
Evidence-Based medicine
guidelines for drug use
recurrence
venous thromboembolism
antithrombins
Direct factor Xa inhibitors
Factor Xa Inhibitors
Factor IIa
dabigatran etexilate
Dabigatran
Rivaroxaban
apixaban
edoxaban
drug interactions
continuity of patient care
clinical chemistry tests
kidney function tests
hemorrhage
surgical procedures, operative
heparin
antivitamins K
patient safety
factor IIa
prothrombin
pyrazoles
pyridones
pyridines
thiazoles
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
https://dumas.ccsd.cnrs.fr/dumas-01363985
2016
false
true
false
France
French
general practitioners
physicians
perception
epidemics
neuraminidase
general practitioners
physicians
perception
influenza, human
disease outbreaks
guideline adherence
dissertations, academic

---
http://www.centreantipoisons.be/professionnels-de-la-sant/articles-pour-professionnels-de-la-sant/intoxications-aigu-s-et-antidote-4
false
true
false
Belgium
patient education handout
flumazenil
antidotes
benzodiazepines

---
http://www.centreantipoisons.be/professionnels-de-la-sant/articles-pour-professionnels-de-la-sant/intoxications-aigu-s-et-antidot-15
false
true
false
Belgium
patient education handout
vitamin K

---
http://www.cfp.ca/content/62/1/e11.full
http://www.cfp.ca/content/62/1/e11.full.pdf+html
2016
false
false
false
Canada
French
journal article
celiac disease
serologic tests
general practice
case reports
child
celiac disease
transglutaminases
immunoglobulin A
Anti-transglutaminase antibody
general practitioners

---
In : Bulletin du Cancer Volume 103, Issue 2, February 2016, Pages 180–189 - Open Access
http://www.sciencedirect.com/science/article/pii/S0007455115003689
2016
false
false
false
Netherlands
French
journal article
nilotinib
nilotinib
protein-tyrosine kinases
leukemia, myeloid, chronic-phase
cardiovascular diseases
risk factors
risk assessment
cardiovascular diseases
practice guideline
Tyrosine Kinase Inhibitors
nilotinib
nilotinib
pyrimidines
pyrimidines

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BCR-ABL-Imatinib-Dasatinib-Nilotinib-Bosutinib-Ponatinib-Medicament-ciblant-JAK-Ruxolitinib-Anticancereux-par-voie-orale-informer-prevenir-et-gerer-leurs-effets-indesirables
2016
false
false
false
France
French
practice guideline
antineoplastic agents
administration, oral
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
information dissemination
patient education as topic
drug interactions
Dasatinib
Imatinib Mesylate
fusion proteins, bcr-abl
protein kinase inhibitors
dasatinib
imatinib
nilotinib
nilotinib
bosutinib
ponatinib
ruxolitinib
janus kinases
ponatinib
ruxolitinib
bosutinib
continuity of patient care
pregnancy
Tyrosine Kinase Inhibitors
nilotinib
ruxolitinib
aniline compounds
nitriles
quinolines
imidazoles
pyridazines
pyrimidines
pyrazoles

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BRAF-en-monotherapie-vemurafenib-dabrafenib-Medicaments-ciblant-BRAF-ou-MEK-en-association-vemurafenib-cobimetinib-dabrafenib-trametinib
2016
false
false
false
France
French
guidelines for drug use
practice guideline
patients guideline
protein kinase inhibitors
protein kinase inhibitors
Drug-Related side effects and adverse reactions
administration, oral
drug interactions
vemurafenib
vemurafenib
antineoplastic combined chemotherapy protocols
vemurafenib
dabrafenib
dabrafenib
dabrafenib
BRAF protein, human
Metastatic Melanoma
melanoma
melanoma
neoplasm metastasis
BRAF Gene Mutation
continuity of patient care
drug monitoring
interdisciplinary communication
protein kinase inhibitors
vemurafenib
dabrafenib
pregnancy
imidazoles
oximes
imidazoles
oximes
proto-oncogene proteins b-raf
imidazoles
oximes
indoles
sulfonamides
indoles
sulfonamides
indoles
sulfonamides
Vemurafenib
Vemurafenib
Vemurafenib

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-inhibiteurs-de-la-voie-Hedgehog-vismodegib
2016
false
false
false
France
French
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patients guideline
practice guideline
vismodegib
vismodegib
vismodegib
vismodegib
antineoplastic agents
antineoplastic agents
antineoplastic agents
carcinoma, basal cell
pregnancy
drug interactions
interdisciplinary communication
Hedgehog Signaling Pathway
signal transduction
hedgehog proteins
continuity of patient care
drug monitoring
HhAntag691
HhAntag691
HhAntag691
anilides
pyridines
anilides
pyridines
anilides
pyridines

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-EGFR-erlotinib-gefitinib-afatinib
2016
false
false
false
France
French
guidelines for drug use
patients guideline
practice guideline
antineoplastic agents
antineoplastic agents
antineoplastic agents
administration, oral
Erlotinib Hydrochloride
Erlotinib Hydrochloride
Erlotinib Hydrochloride
erlotinib
protein kinase inhibitors
protein kinase inhibitors
protein kinase inhibitors
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
drug interactions
pregnancy
carcinoma, non-small-cell lung
interdisciplinary communication
afatinib
afatinib
afatinib
afatinib
gefitinib
Tyrosine Kinase Inhibitors
quinazolines
quinazolines
quinazolines
ErbB Receptors
Gefitinib
Gefitinib
Gefitinib
Afatinib
Afatinib
Afatinib

---
https://medicalforum.ch/fr/detail/doi/fms.2016.02616/
2016
false
false
false
Switzerland
French
review of literature
administration, oral
SGLT2 Inhibitor
Sodium-Glucose transporter 2
diabetes mellitus, type 2
glycosuria
urinary tract infections
risk factors
candidiasis, vulvovaginal
balanitis
candidal balanitis
hypoglycemic agents
candidiasis, vulvovaginal
balanitis
urinary tract infections
SGLT2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

---
http://www.sciencedirect.com/science/article/pii/S0007455116000606
10.1016/j.bulcan.2016.02.001
2016
false
false
false
France
French
pregnancy
Tyrosine Kinase Inhibitor
protein kinase inhibitors
protein-tyrosine kinases
journal article
risk assessment
review of literature
fetus
abortion, spontaneous
abnormalities, drug-induced
antineoplastic agents
Tyrosine Kinase Inhibitors

---
SUNVEPRA - Summary Basis of Decision (SBD)
Asunaprevir, 100 mg , capsule, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00297
2016
false
false
false
false
Canada
French
English
summary of product characteristics
administration, oral
asunaprevir
asunaprevir
NS3 protein, hepatitis C virus
risk assessment
drug evaluation
drug approval
canada
adult
hepatitis C, chronic
drug therapy, combination
Hepatitis C virus genotype 4 (organism)
Hepatitis C virus genotype 1 (organism)
Cirrhosis of liver due to chronic hepatitis C (disorder)
antiviral agents
antiviral agents
protease inhibitors
protease inhibitors
treatment outcome
asunaprevir
isoquinolines
sulfonamides
isoquinolines
sulfonamides
viral nonstructural proteins

---
Summary Safety Review - Bcr-Abl Tyrosine Kinase Inhibitors - Assessing the Potential Harm to the Fetus
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/tki-ikt-fra.php
2016
false
false
false
Canada
French
English
pregnancy
fusion proteins, bcr-abl
protein kinase inhibitors
protein-tyrosine kinases
drug evaluation
risk assessment
fetus
contraception
abnormalities, drug-induced
Tyrosine Kinase Inhibitor
abortion, spontaneous
hematologic diseases
antineoplastic agents
administration, oral
pharmacovigilance
Tyrosine Kinase Inhibitors

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1083/853
2016
false
false
false
false
Canada
French
critical appraisal or critical reading
comparative effectiveness research
angiotensin-converting enzyme inhibitors
enalapril
enzyme inhibitors
angiotensin receptor antagonists
sacubitril and valsartan sodium hydrate drug combination
sacubitril and valsartan sodium hydrate drug combination
enalapril
heart failure
hospitalization
multicenter studies as topic
double-blind method
valsartan and sacubitril
neprilysin
heart failure
enalapril
evaluation studies as topic

---
BCR-ABL Tyrosine Kinase Inhibitors [GLEEVEC (imatinib mesylate), TASIGNA (nilotinib), BOSULIF (bosutinib), SPRYCEL (dasatinib), ICLUSIG (ponatinib hydrochloride)] - Risk of Hepatitis B Reactivation
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58222a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
fusion proteins, bcr-abl
protein kinase inhibitors
Imatinib Mesylate
risk
hepatitis b virus
imatinib
nilotinib
nilotinib
bosutinib
bosutinib
Dasatinib
dasatinib
ponatinib hydrochloride
ponatinib
Tyrosine Kinase Inhibitor
Hepatitis B reactivation
guidelines for drug use
continuity of patient care
mass screening
hepatitis B
hepatitis B
Tyrosine Kinase Inhibitors
nilotinib
ponatinib
pyrimidines
imidazoles
pyridazines
aniline compounds
nitriles
quinolines

---
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58404a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
Sodium-Glucose transporter 2
SGLT2 Inhibitor
Canagliflozin
hypoglycemic agents
dapagliflozin
metformin and dapagliflozin
drug combinations
metformin
empagliflozin
diabetic ketoacidosis
guidelines for drug use
diabetes mellitus, type 2
risk factors
dapagliflozin
canagliflozin
empagliflozin
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
glucosides
benzhydryl compounds

---
http://www.cochrane.org/fr/CD004179/les-anticoagulants-pris-sur-des-durees-prolongees-pour-prevenir-la-thrombose-veineuse-profonde-ou
2016
false
false
false
France
United Kingdom
French
review of literature
french abstract
treatment outcome
venous thrombosis
pulmonary embolism
anticoagulants
drug administration schedule
arthroplasty, replacement, hip
hip prosthesis
arthroplasty, replacement, knee
knee prosthesis
postoperative complications
heparin, low-molecular-weight
vitamin K
anticoagulants
femoral neck fractures
chemoprevention

---
Summary Basis of Decision (SBD) for Bridion
Sugammadex sodium, 100 mg/mL, solution, intravenous
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00283
2016
false
false
false
Canada
French
English
summary of product characteristics
Sugammadex sodium
Sugammadex sodium
injections, intravenous
sugammadex
vecuronium bromide
neuromuscular nondepolarizing agents
anesthesia recovery period
Neuromuscular blockade reversal
adult
risk assessment
neuromuscular blockade
gamma-cyclodextrins
gamma-cyclodextrins
androstanols
Sugammadex
Sugammadex
Rocuronium

---
https://medicalforum.ch/fr/detail/doi/fms.2016.02684/
2016
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
practice guidelines as topic
glucagon-like peptide 1
GLP-1 Mimetics
GLP-1 Mimetics
dipeptidyl-peptidase iv inhibitors
cardiovascular diseases
obesity
Sodium-Glucose transporter 2
SGLT2 Inhibitor
SGLT2 Inhibitor
insulins
risk factors
weight loss
hypoglycemia
insulins
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors

---
https://www.minerva-ebp.be/FR/Article/2056
2016
false
false
false
Belgium
French
french abstract
atrial fibrillation
heparin, low-molecular-weight
anticoagulants
preoperative care
thromboembolism
hemorrhage
vitamin K
Elective Surgical Procedures

---
https://medicalforum.ch/fr/detail/doi/fms.2016.02723/
2016
false
false
false
Switzerland
French
journal article
macular degeneration
aged
aged, 80 and over
macular degeneration
macular degeneration
vascular endothelial growth factors
Drug-Related side effects and adverse reactions

---
Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin, empagliflozin) - Assessing the Potential Risk of Bone-Related Side Effects
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/sglt2-3-fra.php
2016
false
false
false
Canada
French
English
Canagliflozin
hypoglycemic agents
dapagliflozin
Sodium-Glucose transporter 2
SGLT2 Inhibitor
risk assessment
drug evaluation
empagliflozin
adult
diabetes mellitus, type 2
fractures, bone
bone demineralization, pathologic
bone and bones
pharmacovigilance note
product surveillance, postmarketing
canada
dapagliflozin
canagliflozin
empagliflozin
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
benzhydryl compounds
glucosides

---
Summary Safety Review - Tumour Necrosis Factor (TNF) alpha blockers (SIMPONI and CIMZIA) - Assessing the Potential Risk of Liver Inflammation (Autoimmune Hepatitis)
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/tnf-fnt-2-fra.php
2016
false
false
false
Canada
French
tumor necrosis factor-alpha
drug evaluation
risk assessment
hepatitis, autoimmune
canada
Tumor necrosis factor alpha (TNF-α) inhibitors
psoriasis
arthritis, rheumatoid
crohn disease
colitis, ulcerative
golimumab
Certolizumab Pegol
antibodies, monoclonal
Tumor Necrosis Factor Inhibitors

---
http://www.has-sante.fr/portail/jcms/c_2729222/fr/quelle-place-pour-la-transfusion-des-plasmas-therapeutiques
2016
false
false
false
France
French
plasma
guidelines for drug use
fresh frozen plasma
hemorrhage
shock, hemorrhagic
blood component transfusion
disseminated intravascular coagulation
Prothrombin level abnormal
thrombotic microangiopathies
infant, newborn
child
adult
pregnancy
antivitamins K
anticoagulant overdosage, nos
cardiac surgical procedures
coagulation protein disorders
neurosurgical procedures
blood component transfusion
blood component transfusion
blood plasma
Contraindications, Procedure
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
SGLT2 inhibitors
http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-12-fra.php#sglt2
2016
false
false
false
Canada
French
English
drug evaluation
SGLT2 Inhibitor
Sodium-Glucose transporter 2
Canagliflozin
hypoglycemic agents
risk assessment
dapagliflozin
empagliflozin
diabetes mellitus, type 2
fractures, bone
bone demineralization, pathologic
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
glucosides
benzhydryl compounds

---
https://www.inrs.fr/media.html?refINRS=TF%20241
2016
false
false
false
France
French
review of literature
legionellosis
Anti-Tumor Necrosis Factor Therapy
tumor necrosis factors
occupational exposure
risk
occupational diseases
occupational diseases
legionellosis
continuity of patient care
occupational medicine
Pontiac fever
occupational diseases
legionellosis
risk assessment
anti-TNF
Tumor Necrosis Factor Inhibitors

---
https://www.revmed.ch/RMS/2016/RMS-N-509/Spondyloarthropathies-traitements-conventionnels-et-anti-TNF
2016
false
false
false
Switzerland
French
journal article
spondylarthropathies
anti-inflammatory agents, non-steroidal
tumor necrosis factors
anti-TNF
Tumor Necrosis Factor Inhibitors

---
https://pharmacomedicale.org/medicaments/par-specialites/item/stimulants-de-la-cognition-les-points-essentiels
2015
false
false
false
France
French
drug information
cognition disorders
excitatory amino acid antagonists
receptors, n-methyl-d-aspartate
cholinesterase inhibitors
cognition, nos
central nervous system stimulants
cognition
stimulator, nos
essential

---
https://pharmacomedicale.org/medicaments/par-specialites/item/anti-tnf-alpha
2015
false
false
false
France
French
drug information
tumor necrosis factor-alpha
Tumor necrosis factor alpha (TNF-α) inhibitors
Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance)
tumor necrosis factor-alpha
tumor necrosis factor alpha
Tumor Necrosis Factor Inhibitors

---
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=482
http://www.hcsp.fr/Explore.cgi/Telecharger?NomFichier=hcspa20150303_grippesaisrecoutilantiviraux.pdf
2015
false
false
false
France
French
influenza, human
antiviral agents
public health guidelines
neuraminidase
child
adult
aged
influenza, human

---
https://www.minerva-ebp.be/fr/article/1088
2015
false
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
diabetes mellitus, type 2
Sodium-Glucose transporter 2
treatment outcome
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors

---
http://www.revmed.ch/RMS/2015/RMS-N-477/Analogues-du-GLP-1-versus-inhibiteurs-du-SGLT-2-pour-les-diabetiques-de-type-2-obeses
2015
false
false
false
Switzerland
French
diabetes mellitus, type 2
obesity
comparative effectiveness research
treatment outcome
incretins
hypoglycemic agents
Liraglutide
glucagon-like peptide 1
Canagliflozin
Sodium-Glucose transporter 2
SGLT2 Inhibitor
dapagliflozin
empagliflozin
1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol
other blood glucose lowering drugs, excl. insulins
GLP-1 Mimetics
journal article
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
glucosides
benzhydryl compounds
peptides
venoms
sorbitol
sorbitol
Exenatide

---
http://www.societechirorale.com/documents/Recommandations/recommandations_festion_peri_operatoire_2015_court.pdf
http://www.societechirorale.com/documents/Recommandations/recommandations_festion_peri_operatoire_2015_argumentaire.doc
http://www.mbcb-journal.org/articles/mbcb/abs/2015/04/contents/contents.html
http://dx.doi.org/10.1051/mbcb/2015036
2015
false
true
false
France
French
fibrinolytic agents
practice guideline
oral surgical procedures
risk assessment
postoperative hemorrhage
hemostatics
vitamin K
anticoagulants
Identifying Risk For Haemorrhaging
Risk For Haemorrhaging
heparin
platelet aggregation inhibitors
antivitamins K
antivitamins K
journal article
Therapy cessation
anticoagulotherapy
indenes
4-hydroxycoumarins
indenes
4-hydroxycoumarins

---
http://www.e-cancer.fr/content/download/126025/1524695/file/Médicaments%20ciblant%20BCR-ABL.pdf
2015
false
false
false
France
French
practice guideline
guidelines for drug use
administration, oral
antineoplastic agents
Drug-Related side effects and adverse reactions
imatinib
dasatinib
nilotinib
nilotinib
bosutinib
bosutinib
ponatinib
ponatinib
protein kinase inhibitors
ruxolitinib
ruxolitinib
janus kinases
information dissemination
continuity of patient care
hospital-physician relations
hospital-patient relations
physician-patient relations
drug interactions
pregnancy
protein-tyrosine kinases
Tyrosine Kinase Inhibitor
Dasatinib
Imatinib Mesylate
Tyrosine Kinase Inhibitors
nilotinib
ruxolitinib
pyrazoles
aniline compounds
nitriles
quinolines
imidazoles
pyridazines

---
https://www.jle.com/fr/revues/hpg/e-docs/les_manifestations_cutanees_des_anti_tnf_alpha_305568/article.phtml
2015
false
false
false
France
French
journal article
tumor necrosis factor-alpha
tumor necrosis factor-alpha
case reports
image
skin diseases
algorithms
examination questions
Dermatitis psoriasiform
Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance)
Tumor Necrosis Factor Inhibitors

---
https://devsante.org/articles/interactions-medicamenteuses-avec-les-anticoagulants
2015
false
false
false
false
France
French
anticoagulants
drug interactions
drug information
thromboembolism
continuity of patient care
anticoagulants
administration, oral
hemorrhage
injections, subcutaneous
vitamin k antagonists
heparin
antivitamins K
aspirin
heparin group
acetylsalicylic acid
platelet aggregation inhibitors
journal article
antivitamins K
anticoagulotherapy
indenes
vitamin K
vitamin K
4-hydroxycoumarins
indenes
4-hydroxycoumarins

---
http://www.has-sante.fr/portail/jcms/c_1741768/fr/guide-parcours-de-soins-fibrillation-atriale
http://www.has-sante.fr/portail/jcms/c_1741766/fr/guide-parcours-de-soins-fibrillation-atriale
2014
true
France
French
atrial fibrillation
practice guideline
disease management
general practice
atrial fibrillation
atrial fibrillation
anticoagulants
algorithms
continuity of patient care
vitamin K
hemorrhage
pregnancy
anticoagulotherapy
general practitioners

---
http://www.has-sante.fr/portail/jcms/c_1751169/fr/benlysta
http://www.has-sante.fr/portail/jcms/c_1234522/benlysta
2014
false
France
French
evaluation of the transparency committee
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
guidelines for drug use
secondary prevention
corticosteroid therapy
belimumab
belimumab
antibodies, monoclonal
antibodies, monoclonal
belimumab
immunosuppressive agents
immunosuppressive agents
TNFSF13B protein, human
b-cell activating factor
lupus erythematosus, systemic
treatment outcome
drug therapy, combination
adult
infusions, intravenous
randomized controlled trials as topic
risk management
clinical trials, phase iii as topic
antibodies, antinuclear
Tumor Necrosis Factor Inhibitors

---
http://www.cochrane.org/fr/CD005208
2014
false
false
false
United Kingdom
France
stroke
platelet glycoprotein GPIIb-IIIa complex
cerebral hemorrhage
treatment outcome
aspirin
acute disease
platelet aggregation inhibitors
platelet aggregation inhibitors
meta-analysis
french abstract
antibodies, monoclonal
immunoglobulin fab fragments
Abciximab

---
http://www.cochrane.org/fr/CD004452
2014
false
false
false
United Kingdom
France
barusiban
atosiban
tocolytic agents
barusiban
atosiban
tocolytic agents
treatment outcome
pregnancy
meta-analysis
french abstract
obstetric labor, premature
receptors, oxytocin
oligopeptides
vasotocin
vasotocin
oligopeptides
vasotocin

---
http://www.cochrane.org/fr/CD008139
2014
false
true
false
United Kingdom
France
neuraminidase
treatment outcome
review of literature
french abstract
cystic fibrosis
neuraminidase
influenza, human

---
http://www.cochrane.org/fr/CD001367
2014
false
false
false
United Kingdom
France
anticoagulants
treatment outcome
venous thromboembolism
secondary prevention
recurrence
anticoagulotherapy
meta-analysis
french abstract
vitamin K
venous thromboembolism
time factors

---
http://www.cochrane.org/fr/CD006468
2014
false
false
false
France
United Kingdom
thrombosis
treatment outcome
neoplasms
heparin
vitamin K
anticoagulotherapy
meta-analysis
french abstract
central venous catheters
anticoagulants

---
http://www.cochrane.org/fr/CD007325
2014
false
false
false
France
United Kingdom
treatment outcome
meta-analysis
french abstract
macular edema
retinal vein occlusion
endothelial growth factors

---
http://www.sciencedirect.com/science/article/pii/S1169833013002858
http://www.has-sante.fr/portail/jcms/c_1701342/fr/label-de-la-has-anti-tnf-conseils-dutilisation-et-recommandations-de-bonne-pratique
2014
false
true
true
false
France
French
journal article
practice guideline
spondylarthropathies
spondylarthropathies
spondylarthropathies
spondylarthropathies
anti-inflammatory agents, non-steroidal
tumor necrosis factors
spondylarthropathies
Tumor Necrosis Factor Inhibitors

---
http://www.cochrane.org/fr/CD009893/les-inhibiteurs-directs-de-la-thrombine-par-rapport-aux-antagonistes-de-la-vitamine-k-chez-les-patients-souffrant-de-fibrillation-auriculaire-pour-prevenir-laccident-vasculaire-cerebral-avc
2014
false
false
false
France
United Kingdom
French
meta-analysis
atrial fibrillation
vitamin K
stroke
treatment outcome
french abstract
antithrombins
antithrombins
anticoagulants
anticoagulotherapy

---
http://www.academie-medecine.fr/rapport-sur-les-anticoagulants-oraux-directs-aod-anterieurement-appeles-nouveaux-anticoagulants-oraux-ou-naco/
http://www.academie-medecine.fr/wp-content/uploads/2014/06/aod2805.pdf
2014
false
false
false
false
France
French
anticoagulants
administration, oral
technical report
anticoagulants
drug interactions
thromboembolism
anticoagulants
pyridines
apixaban
pyrazoles
pyridones
atrial fibrillation
antithrombins
thiazoles
edoxaban
acute coronary syndrome
anticoagulants
vitamin K
orthopedic procedures
anticoagulotherapy
Dabigatran
Dabigatran
Rivaroxaban

---
https://medicalforum.ch/fr/detail/doi/fms.2014.02112/
2014
false
false
false
Switzerland
French
journal article
neuroendocrine tumors
receptors, somatostatin
radiopharmaceuticals

---
http://www.amub-ulb.be/revue-medicale-bruxelles/article/les-nouveaux-anti-diabetiques-oraux-1032
2014
false
false
false
false
Belgium
French
journal article
comparative study
diabetes mellitus, type 2
incretins
hypoglycemic agents
administration, oral
incretins
gastric inhibitory polypeptide
glucagon-like peptide 1
dipeptidyl-peptidase iv inhibitors
dipeptidyl peptidase 4 (DPP-4) inhibitors
other blood glucose lowering drugs, excl. insulins
incretins
hypoglycemic agents
hypoglycemic agents
SLC5A2 protein, human
risk factors
drug therapy, combination
treatment outcome
Glucagon-Like Peptide-1 Receptor
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose transporter 2

---
https://www.revmed.ch/RMS/2014/RMS-N-416/Pourquoi-quand-et-comment-doser-les-nouveaux-anticoagulants-oraux
2014
false
false
false
Switzerland
French
journal article
thromboembolism
continuity of patient care
drug monitoring
anticoagulants
administration, oral
rivaroxaban
apixaban
dabigatran etexilate
apixaban
risk factors
blood coagulation tests
kidney failure, chronic
factor xa
antithrombins
Factor Xa Inhibitors
Rivaroxaban
Dabigatran
pyrazoles
pyridones

---
https://www.revmed.ch/RMS/2014/RMS-N-416/Gestion-peri-interventionnelle-des-nouveaux-anticoagulants-oraux-directs
2014
false
false
false
Switzerland
French
journal article
administration, oral
anticoagulants
factor xa
perioperative care
postoperative hemorrhage
blood loss, surgical
anticoagulants
apixaban
antithrombins
antithrombins
Factor Xa Inhibitors
Therapy cessation
anticoagulotherapy
Dabigatran
Rivaroxaban
pyrazoles
pyridones

---
https://www.revmed.ch/RMS/2014/RMS-N-416/Nouveaux-anticoagulants-oraux-donnees-pharmacologiques-a-connaitre-pour-la-pratique-clinique
2014
false
false
false
Switzerland
French
journal article
anticoagulants
administration, oral
antithrombins
factor xa
apixaban
thromboembolism
thromboembolism
drug interactions
renal insufficiency
hepatic insufficiency
aged
obesity
anticoagulants
antithrombins
Factor Xa Inhibitors
anticoagulotherapy
Rivaroxaban
Dabigatran
pyrazoles
pyridones

---
http://ageps.aphp.fr/wp-content/blogs.dir/68/files/2015/05/Recommandations-antithrombotiques-COMEDIMS-APHP-AGEPS-2014-Oct.pdf
2014
false
false
true
France
French
guidelines for drug use
platelet aggregation inhibitors
anticoagulants
venous thromboembolism
deep vein thrombosis
antivitamins K
heparin
administration, oral
injections, subcutaneous
bivalirudin
apixaban
venous thrombosis
venous thrombosis
postoperative complications
atrial fibrillation
heart valve diseases
heart valve prosthesis implantation
acute coronary syndrome
myocardial ischemia
algorithms
adult
aged
pregnancy
contraceptives, oral
venous thromboembolism
continuity of patient care
antiphospholipid syndrome
renal insufficiency
obesity
cachexia
hemorrhage
anticoagulants
vitamin K
antithrombins
antithrombotic agents
Factor Xa Inhibitors
drug monitoring
hematologic tests
international normalized ratio
anticoagulotherapy
Rivaroxaban
Dabigatran
venous thrombosis
danaparoid
chondroitin sulfates
dermatan sulfate
heparitin sulfate
indenes
4-hydroxycoumarins
polysaccharides
hirudins
peptide fragments
recombinant proteins
pyrazoles
pyridones
Fondaparinux

---
http://www.cochrane.org/fr/CD002130
2013
false
true
false
France
United Kingdom
platelet membrane glycoproteins
acute coronary syndrome
treatment outcome
review of literature
french abstract
percutaneous coronary intervention

---
http://www.cochrane.org/fr/CD005938
2013
false
true
false
United Kingdom
France
obstetric labor, premature
obstetric labor, premature
oxytocin
treatment outcome
review of literature
french abstract
oxytocin

---
http://www.sfdermato.org/media/pdf/recommandation/traitements-anti-tnf-recos-64222d1c6f9c32cb666ec9ac141d2349.pdf
2013
true
France
French
continuity of patient care
autoimmune diseases
risk assessment
neoplasms
mass screening
neoplasms
hematologic diseases
herpesviridae infections
herpesvirus 3, human
herpes simplex
malaria
histoplasmosis
legionellosis
hepatitis B
hepatitis C
vaccines
vaccination
pregnancy
surgical procedures, operative
aged
tumor necrosis factor-alpha
guidelines for drug use
journal article
antibodies, monoclonal
antibodies, monoclonal
antirheumatic agents
antirheumatic agents
Tumor necrosis factor alpha (TNF-α) inhibitors
Tumor Necrosis Factor Inhibitors

---
https://www.revmed.ch/RMS/2013/RMS-375/Calcifications-vasculaires-et-deficit-en-vitamine-K-un-facteur-de-risque-modifiable-dans-l-insuffisance-renale-chronique
2013
Switzerland
French
vascular calcification
renal insufficiency, chronic
journal article
vitamin K 2
vitamin K
anticoagulants
vitamin k deficiency

---
https://www.inspq.qc.ca/publications/1713
https://www.inspq.qc.ca/sites/default/files/publications/1713_rapsurvlaboenterobaccarbapisoleesqc.pdf
2013
false
true
false
Canada
drug resistance, bacterial
biosurveillance
enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae
technical report
quebec
enterobacteriaceae
carbapenems

---
http://www.cochrane.org/fr/CD003986
2012
United Kingdom
France
French
review of literature
craniocerebral trauma
treatment outcome
excitatory amino acids
excitatory amino acid antagonists
french abstract

---
https://rmlg.uliege.be/article/2275
2012
Belgium
French
tumor necrosis factors
tumor necrosis factors
journal article
psoriasis
image
eczema
skin diseases
Tumor Necrosis Factor Inhibitors

---
http://www.cochrane.org/fr/CD007419
2012
false
France
United Kingdom
French
french abstract
meta-analysis
macular edema
diabetic retinopathy
angiogenesis inhibitors
vascular endothelial growth factors
treatment outcome
Diabetic macular oedema
diabetes complications

---
https://www.revmed.ch/RMS/2012/RMS-351/Y-a-t-il-encore-une-place-pour-la-double-inhibition-du-systeme-renine-angiotensine-en-2012
2012
Switzerland
French
renin-angiotensin system
journal article
Renin-angiotensin system inhibition
angiotensin-converting enzyme inhibitors
angiotensin II type 1 receptor blockers
renin
aliskiren
amides
fumarates

---
http://campus.cerimes.fr/cardiologie-et-maladies-vasculaires/enseignement/cardio_182/site/html/
http://campus.cerimes.fr/cardiologie-et-maladies-vasculaires/enseignement/cardio_182/site/html/cours.pdf
http://campus.cerimes.fr/cardiologie-et-maladies-vasculaires/enseignement/cardio_182/site/html/1.html
2012
true
France
French
anticoagulotherapy
educational course
French pre-residency program examination
anticoagulants
Drug-Related side effects and adverse reactions
heparin
vitamin K
heparin

---
http://www.cochrane.org/fr/CD002744
2012
false
United Kingdom
France
French
Substance with neuraminidase inhibitor mechanism of action (substance)
meta-analysis
influenza, human
child
influenza, human
antiviral agents
neuraminidase
enzyme inhibitors
infant
french abstract

---
https://ansm.sante.fr/uploads/2021/03/11/6d550a9311848623e57d311cc0ebacbe.pdf
2012
false
France
French
secondary prevention
antivitamins K
anticoagulotherapy
antivitamins K
anticoagulants
vitamin K
guidelines for drug use
risk assessment
international normalized ratio
continuity of patient care
patient education as topic
administration, oral
acenocoumarol
fluindione
warfarin
Warfarin Sodium
fluindione
warfarin
acenocoumarol
thromboembolism
venous thrombosis
pulmonary embolism
heart diseases
heart diseases
myocardial infarction
heart valve prosthesis
drug monitoring
drug interactions
pregnancy
breast feeding
phenindione
indenes
4-hydroxycoumarins

---
http://www.has-sante.fr/portail/jcms/c_1355322/zelboraf-vemurafenib-inhibiteur-de-la-proteine-kinase-braf
http://www.has-sante.fr/portail/jcms/c_1355321/zelboraf-synthese-ct12121
2012
France
French
melanoma
evaluation of the transparency committee
guidelines for drug use
vemurafenib
indoles
sulfonamides
proto-oncogene proteins b-raf
Vemurafenib

---
http://www.cochrane.org/fr/CD002122
2012
United Kingdom
France
French
review of literature
endometriosis
pain management
treatment outcome
progesterone congeners
progestins
pelvic pain
french abstract

---
http://www.fmcgastro.org/postu-main/archives/postu-2012-%e2%80%93-paris/textes-postu-2012-paris/tolerance-aux-biotherapies
2012
false
true
false
false
France
anti-TNF
Infliximab
Adalimumab
immunocompromised host
neoplasms
mass screening
crohn disease
colitis, ulcerative
inflammatory bowel diseases
inflammatory bowel diseases
Infections
opportunistic infections
skin diseases
joint diseases
nervous system diseases
inflammatory bowel diseases
antibodies, monoclonal
tumor necrosis factors
gastrointestinal agents
Infliximab
Adalimumab
Contraindications, Procedure
teaching material
Contraindications, Drug
Tumor Necrosis Factor Inhibitors

---
http://www.fmcgastro.org/postu-main/archives/postu-2012-%e2%80%93-paris/textes-postu-2012-paris/atelier-utilisation-des-anticorps-anti-tnf-a-dans-la-prise-en-charge-des-patients-atteints-de-maladies-inflammatoires-chroniques-intestinales-mici
2012
false
true
false
false
France
anti-TNF
crohn disease
colitis, ulcerative
inflammatory bowel diseases
Infliximab
Adalimumab
Infliximab
Adalimumab
tumor necrosis factors
gastrointestinal agents
teaching material
inflammatory bowel diseases
Contraindications, Drug
Tumor Necrosis Factor Inhibitors

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/881
2012
false
false
false
Canada
drug eruptions
Tyrosine Kinase Inhibitors
journal article
patient care management
growth factors
ErbB Receptors

---
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_outil_choix_anticoagulotherapie.pdf
2012
false
true
false
Canada
factor xa
anticoagulants
anticoagulants
anticoagulants
anticoagulants
Rivaroxaban
technical report
atrial fibrillation
adult

---
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=297
http://www.hcsp.fr/explore.cgi/hcspr20121109_antivirauxextrahospgrippe.pdf
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=298
2012
France
French
influenza, human
public health guidelines
guideline
neuraminidase
neuraminidase
neuraminidase inhibitors
treatment outcome
antiviral agents

---
http://www.cochrane.org/fr/CD007687
2012
United Kingdom
France
French
meta-analysis
mifepristone
leiomyoma
treatment outcome
receptors, progesterone
french abstract

---
https://www.inspq.qc.ca/sites/default/files/publications/1566_medsysthormonalcanicules.pdf
2012
false
Canada
French
corticosteroid therapy
Ezetimibe
extreme heat
risk factors
administration, oral
hypoglycemic agents
quebec
Drug-Related side effects and adverse reactions
hypolipidemic agents
population characteristics
Bibliographies as Topic
thyroid hormones
renal insufficiency
glyburide
iodine radioisotopes
mineralocorticoids
bromocriptine
insulin
dehydration
alpha-Glucosidases
alpha glucosidase inhibitors
guidelines for drug use
practice guideline
biguanides
biguanides
dipeptidyl peptidase 4 (DPP-4) inhibitors
dipeptidyl-peptidase iv inhibitors
glucagon-like peptide 1
water-electrolyte imbalance
niacin
nicotinic acid
bile acid sequestrants
fibrates
fibric acids
hmg coa reductase inhibitors
hydroxymethylglutaryl-coa reductase inhibitors
ezetimibe
anion exchange resins
reports and studies
thyroid hormones
diphosphonates
imidazoles
Zoledronic Acid

---
http://www.has-sante.fr/portail/jcms/c_1294163/roactemra-tocilizumab-inhibiteur-de-linterleukine-6
http://www.has-sante.fr/portail/jcms/c_1294071/roactemra-aji-synthese-09052012
http://www.has-sante.fr/portail/jcms/c_1250744/roactemra-09052012-avis-ct-11877
2012
false
France
French
evaluation of the transparency committee
tocilizumab
receptors, interleukin-6
tocilizumab
tocilizumab
arthritis, juvenile
child
treatment outcome
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
infusions, intravenous
drug therapy, combination
continuity of patient care
clinical trials as topic
drug monitoring
risk management

---
https://rmlg.uliege.be/article/2276
2012
Belgium
French
crohn disease
tumor necrosis factors
journal article
Tumor Necrosis Factor Inhibitors

---
http://www.has-sante.fr/portail/jcms/c_1191381/tamiflu-oseltamivir-antiviral-inhibiteur-de-la-neuraminidase
http://www.has-sante.fr/portail/jcms/c_1191332/tamiflu-02112011-synthese-ct9677
http://www.has-sante.fr/portail/jcms/c_1147021/tamiflu-02-11-2011-avis-ct-9677
2012
false
France
French
Substance with neuraminidase inhibitor mechanism of action (substance)
oseltamivir
antiviral agents
enzyme inhibitors
neuraminidase
administration, oral
influenza, human
adult
child
oseltamivir
treatment outcome
infant
pandemics
influenza, human
Post-Exposure prophylaxis
follow-up studies
insurance, health, reimbursement
evaluation of the transparency committee
guidelines for drug use

---
https://www.ema.europa.eu/medicines/human/EPAR/Benlysta
2012
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
syndication feed
belimumab
belimumab
drug approval
treatment outcome
infusions, intravenous
adult
lupus erythematosus, systemic
antibodies, monoclonal
antibodies, monoclonal
belimumab
b-cell activating factor
TNFSF13B protein, human
Tumor Necrosis Factor Inhibitors

---
https://www.ema.europa.eu/medicines/human/EPAR/Bridion
2012
United Kingdom
French
English
syndication feed
gamma-cyclodextrins
gamma-cyclodextrins
antidotes
drug approval
drug labeling
treatment outcome
injections, intravenous
adult
child
adolescent
vecuronium bromide
neuromuscular nondepolarizing agents
androstanols
anesthesia recovery period
respiratory muscles
neuromuscular blockade
aged
monitoring, physiologic
drug interactions
breast feeding
drug evaluation, preclinical
antidotes
pregnancy
drug incompatibility
drug storage
drug compounding
sugammadex
androstanols
gamma-cyclodextrins
package leaflet
drug evaluation
summary of product characteristics
Sugammadex
Sugammadex
Rocuronium

---
https://www.revmed.ch/RMS/2011/RMS-278/Allergo-immunologie.-1.-Nouveautes-dans-le-traitement-des-crises-aigues-d-angioedeme-hereditaire
2011
false
true
false
Switzerland
bradykinin
angioedemas, hereditary
receptors, bradykinin
icatibant
journal article
angioedemas, hereditary
bradykinin

---
https://www.jle.com/fr/revues/medecine/gpn/e-docs/00/04/65/DF/resume.phtml
2011
France
French
antivitamins K
anticoagulotherapy
aged
guideline adherence
journal article
atrial fibrillation
vitamin K
anticoagulants
antivitamins K
indenes
4-hydroxycoumarins

---
http://unt-ori2.crihan.fr/unspf/2011_Angers_Faure_Angiotensine/co/syst_angiotensine_web.html
2011
false
true
France
renin-angiotensin system
educational course
problems and exercises
multiple choice quizz
agents acting on the renin-angiotensin system
angiotensin-converting enzyme inhibitors
angiotensin-converting enzyme inhibitors
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
pharmacology
renin
drug interactions
hypertension
heart failure
myocardial infarction
diabetic nephropathies
education, pharmacy

---
https://www.inspq.qc.ca/sites/default/files/publications/1272_resistanceantituberculeux_2010.pdf
2011
false
true
false
Canada
drug resistance, bacterial
tuberculosis
technical report
quebec
antitubercular agents

---
https://rmlg.uliege.be/article/2155
2011
false
true
false
Belgium
excitatory amino acid agents
depression
depression
depressive disorder
depressive disorder
tumor necrosis factor-alpha
journal article
excitatory amino acid agents
antidepressive agents
Tumor Necrosis Factor Inhibitors

---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/CEPO-Anti-EGFR_et_colorectal_(2011-08-19).pdf
2011
false
false
Canada
French
colorectal neoplasms
treatment outcome
neoplasm metastasis
Tyrosine Kinase Inhibitors
practice guideline
ErbB Receptors
ErbB Receptors

---
http://www.has-sante.fr/portail/jcms/c_1009982/biologie-des-anomalies-de-lhemostase-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084558/biologie-anomalie-hemostase-t1-temps-de-saignement-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084559/biologie-anomalie-hemostase-t2-thrombine-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084560/biologie-anomalie-hemostase-t3-tap-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084561/biologie-anomalie-hemostase-t4-ac-anti-f4p-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084562/biologie-anomalie-hemostase-t5-inhibiteurs-fah-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084563/biologie-anomalie-hemostase-t6-al-rapport-d-evaluation
http://www.has-sante.fr/portail/jcms/c_1084564/biologie-anomalie-hemostase-t7-mutations-fii-et-fv-rapport-d-evaluation
2011
true
France
French
health technology assessment
hemostatic disorders
bleeding time
thrombin time
platelet aggregation
platelet factor 4
factor VIII
lupus coagulation inhibitor
factor v
prothrombin
factor V leiden

---
https://www.revmed.ch/RMS/2011/RMS-277/Rhumatologie.-ANTI-TNFa-quels-risques-infectieux-Recommandations-pratiques
2011
Switzerland
French
journal article
rheumatic diseases
tumor necrosis factor-alpha
tumor necrosis factor-alpha
tumor necrosis factor-alpha
Infections
Tumor Necrosis Factor Inhibitors

---
http://www.cochrane.org/fr/CD005981
2011
false
true
false
United Kingdom
France
arthroplasty
treatment outcome
review of literature
french abstract
antithrombins
vitamin K
venous thromboembolism
heparin, low-molecular-weight

---
http://www.cochrane.org/fr/CD007066
2011
false
true
false
United Kingdom
France
antihypertensive agents
treatment outcome
review of literature
french abstract
hypertension
renin

---
https://www.jle.com/fr/revues/nro/e-docs/les_inhibiteurs_du_facteur_xa_289391/article.phtml
2010
false
France
French
Factor Xa Inhibitors
Rivaroxaban
journal article
factor xa
atrial fibrillation
DERMATITIS
fibrinolytic agents
stroke
edoxaban
apixaban
pyrazoles
pyridones
pyridines
thiazoles
Direct factor Xa inhibitors

---
http://www.inesss.qc.ca/fileadmin/doc/CDM/UsageOptimal/AINS-IPP/CdM-Principes-IPP.pdf
2010
Canada
French
lansoprazole
rabeprazole
2-Pyridinylmethylsulfinylbenzimidazoles
canada
proton pump inhibitors
proton pump inhibitors
dyspepsia
dyspepsia
anti-inflammatory agents, non-steroidal
aspirin
peptic ulcer
peptic ulcer
drug utilization review
gastroesophageal reflux
proton pump inhibitors
omeprazole
H(+)-K(+)-Exchanging ATPase
peptic ulcer
guidelines for drug use
Pantoprazole

---
https://www.revmed.ch/RMS/2010/RMS-235/Introduction-de-l-acenocoumarol-a-l-aide-d-un-algorithme-de-prescription
2010
false
Switzerland
French
antivitamins K
journal article
narrow therapeutic range drugs
anticoagulants
antivitamins K
vitamin K
acenocoumarol
indenes
4-hydroxycoumarins

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-03/tracleer_-_ct-7227.pdf
http://www.has-sante.fr/portail/jcms/c_946222/tracleer-32-mg-bosentan-antagoniste-des-recepteurs-de-lendotheline
2010
false
France
French
receptor, endothelin b
hypertension, pulmonary
administration, oral
orphan drug production
bosentan
treatment outcome
skin ulcer
scleroderma, systemic
fingers
evaluation of the transparency committee
guidelines for drug use
Bosentan

---
http://www.cochrane.org/fr/CD008088
2010
United Kingdom
France
French
Cancer Pain
review of literature
endometriosis
pelvic pain
treatment outcome
tumor necrosis factor-alpha
anti-inflammatory agents
french abstract
Tumor Necrosis Factor Inhibitors

---
http://www.snfge.org/download/file/fid/68
2010
France
French
inflammatory bowel diseases
tumor necrosis factors
checklist
scientific and technical information
Tumor Necrosis Factor Inhibitors

---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/asthme/documents/education-therapeutique-du-patient-modeles-pratiques-et-evaluation
http://portaildocumentaire.santepubliquefrance.fr/exl-php/vue-consult/spf___internet_recherche/INP00011657
2010
false
France
French
pediatric obesity
Cancer Pain
Cancer Pain
Cancer pain
patient education as topic
diabetes mellitus, type 1
diabetes mellitus, type 2
child
adolescent
obesity
adult
cardiovascular diseases
hiv infections
asthma
neoplasms
arthritis, rheumatoid
low back pain
vitamin K
acquired immunodeficiency syndrome
scientific and technical information
Childhood asthma (disorder)

---
http://www.cochrane.org/fr/CD001867
2010
United Kingdom
France
French
meta-analysis
alcohol-related disorders
narcotic antagonists
treatment outcome
naltrexone
french abstract

---
http://www.revmed.ch/RMS/2010/RMS-N-267/Y-a-t-il-une-place-aujourd-hui-pour-les-inhibiteurs-directs-de-la-renine
2010
false
true
false
Switzerland
hypertension
aliskiren
antihypertensive agents
antihypertensive agents
antihypertensive agents
antihypertensive agents
heart failure
diabetic nephropathies
Substance with renin inhibitor mechanism of action (substance)
journal article
renin
amides
fumarates

---
http://www.lecofer.org/index.php?rub=2cycle&ssrub=cas
http://campus.cerimes.fr/rhumatologie/enseignement/rhumato27/site/html/
2009
true
2eme cycle / master
France
French
antivitamins K
anticoagulotherapy
French pre-residency program examination
Contraindications, Procedure
rheumatology
anticoagulants
vitamin K
drug interactions
iatrogenic disease
hematoma
hematoma
signs and symptoms
medical history taking
hematoma
injections, Intra-Articular
injections, spinal
platelet aggregation inhibitors
hemarthrosis
acute disease
hemarthrosis
anticoagulants
anticoagulants
antivitamins K
educational course
case reports
indenes
4-hydroxycoumarins
Contraindications, Drug

---
http://www.lecrat.eu/?s=Acide+clavulanique
2009
France
French
clavulanic acid
beta-Lactamases
enzyme inhibitors
pregnancy
breast feeding
amoxicillin and beta-lactamase inhibitor
ticarcillin and beta-lactamase inhibitor
drug information

---
https://www.jle.com/fr/revues/bio_rech/jpc/e-docs/00/04/4D/17/resume.phtml?type=text.html
2009
France
English
French
antivitamins K
vitamin K
anticoagulants
anticoagulants
hemorrhage
comorbidity
drug interactions
hypertension
sex factors
age factors
international normalized ratio
amiodarone
proton pump inhibitors
warfarin
administration, oral
case-control studies
risk factors
emergency service, hospital
antivitamins K
antivitamins K
journal article
drug overdose
indenes
4-hydroxycoumarins

---
https://www.cadth.ca/fr/les-anti-tnf-dans-la-prise-en-charge-des-maladies-inflammatoires-chroniques-de-lintestin
https://www.cadth.ca/sites/default/files/pdf/O0479_Anti_TNF_a_Drugs_for_Refractory_Inflammatory_Bowel_Disease_to_fr.pdf
2009
true
Canada
English
French
Adalimumab
Infliximab
tumor necrosis factor-alpha
Cost-Benefit analysis
drug costs
treatment outcome
gastrointestinal agents
gastrointestinal agents
crohn disease
proctocolitis
anti-inflammatory agents
anti-inflammatory agents
canada
randomized controlled trials as topic
patient care management
immunoglobulin G
receptors, tumor necrosis factor
drug evaluation
economic evaluation
comparative study
Tumor Necrosis Factor Inhibitors

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2009/13327a-fra.php
2009
Canada
English
French
antirheumatic agents
neoplasms
tumor necrosis factor-alpha
child
drug labeling
pharmacovigilance note
Tumor Necrosis Factor Inhibitors

---
https://ansm.sante.fr/uploads/2021/03/11/ae4209ebc36d7164d4b7c876ddeaabab.pdf
2009
true
France
French
antivitamins K
anticoagulotherapy
venous thromboembolism
venous thrombosis
stockings, compression
heparin
heparin, low-molecular-weight
stroke
fibrinolytic agents
aspirin
intracranial hemorrhages
thrombosis
catheterization
neoplasms
venous thrombosis
pulmonary embolism
acute disease
ambulatory care
venous thromboembolism
anticoagulants
time
vitamin K
vena cava filters
anticoagulants
antivitamins K
antivitamins K
practice guideline
indenes
4-hydroxycoumarins

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F36F11F
2009
Belgium
Dutch
French
ATP Binding Cassette Transporter, Subfamily B, Member 1
drug interactions
cytochrome p-450 cyp3a
colchicine
journal article
pharmacovigilance note

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-10/firmagon_-_ct-6725.pdf
http://www.has-sante.fr/portail/jcms/c_928075/firmagon-degarelix-antagoniste-de-la-gnrh
2009
France
French
gonadotropin-releasing hormone
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
oligopeptides
insurance, health, reimbursement
degarelix
antineoplastic agents
injections, subcutaneous
treatment outcome
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
oligopeptides
prostatic neoplasms
neoplasms, hormone-dependent
antineoplastic agents
degarelix
degarelix
evaluation of the transparency committee
guidelines for drug use

---
http://www.has-sante.fr/portail/jcms/c_930285/erbitux-cetuximab-anticorps-monoclonal-anti-egfr-kras-sauvage
2009
false
France
French
guidelines for drug use
Cetuximab
antineoplastic agents
infusions, intravenous
Tyrosine Kinase Inhibitors
cetuximab
colorectal neoplasms
neoplasm metastasis
antineoplastic combined chemotherapy protocols
colorectal neoplasms
KRAS protein, human
proto-oncogene proteins
ras proteins
treatment outcome
survival rate
disease-free survival
evaluation of the transparency committee
ErbB Receptors

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/4A/6A/resume.phtml?type=text.html
2009
France
French
journal article
Tyrosine Kinase Inhibitors
carcinoma, hepatocellular
epidermal growth factor
receptors, vascular endothelial growth factor
vascular endothelial growth factor a
carcinoma, hepatocellular
antibodies, monoclonal
ErbB Receptors

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/52/0D/resume.phtml?type=text.html
2009
false
France
French
journal article
Cetuximab
Bevacizumab
Tyrosine Kinase Inhibitors
antibodies, monoclonal
colorectal neoplasms
colorectal neoplasms
genes, ras
ErbB Receptors
Panitumumab

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/52/13/resume.phtml
2009
France
French
journal article
Tyrosine Kinase Inhibitors
antineoplastic agents
drug eruptions
folliculitis
ErbB Receptors

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/47/C8/resume.phtml?type=text.html
2009
France
French
journal article
Tyrosine Kinase Inhibitors
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
angiogenesis inhibitors
ErbB Receptors

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/47/09/resume.phtml
2009
France
French
journal article
Tyrosine Kinase Inhibitors
antibodies, monoclonal
carcinoma, non-small-cell lung
head and neck neoplasms
lung neoplasms
receptor, erbB-2
ErbB Receptors

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/47/0A/resume.phtml
2009
France
French
journal article
Tyrosine Kinase Inhibitors
angiogenesis inhibitors
lung neoplasms
otorhinolaryngologic neoplasms
receptors, vascular endothelial growth factor
vascular endothelial growth factor a
antibodies, monoclonal

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/47/0B/resume.phtml
2009
France
French
journal article
head and neck neoplasms
intracellular signaling peptides and proteins
lung neoplasms
Protein Serine-Threonine Kinases
proto-oncogene proteins c-akt

---
http://www.cochrane.org/fr/CD003086
2009
United Kingdom
France
French
Opioid withdrawal
meta-analysis
smoking cessation
opiate antagonist, nos
analgesics, opioid
treatment outcome
analgesics, opioid
french abstract

---
https://ansm.sante.fr/uploads/2021/03/12/5e41e9188c8a23330bc0f0461821d691.pdf
2009
false
France
French
antivitamins K
anticoagulants
anticoagulants
child
aged
anticoagulants
anticoagulants
drug interactions
pregnancy
anticoagulants
anticoagulants
vitamin K
antivitamins K
antivitamins K
vitamin k antagonists
guidelines for drug use
indenes
4-hydroxycoumarins
Contraindications, Drug

---
http://cemv.vascular-e-learning.net/poly/revisions/Autres/AVK/index.html
2008
false
true
false
false
France
antivitamins K
vitamin K
vitamin K
anticoagulants
hematology
anticoagulotherapy
French pre-residency program examination
audiovisual aids

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F35F01H
2008
Belgium
French
antivitamins K
aged
anticoagulants
vitamin K
antivitamins K
vitamin k antagonists
journal article
indenes
4-hydroxycoumarins

---
https://rmlg.uliege.be/article/1699
2008
Belgium
French
piperidines
pyrazoles
receptor, cannabinoid, CB1
journal article
Rimonabant

---
https://rmlg.uliege.be/article/1790
2008
false
Belgium
French
Substance with renin inhibitor mechanism of action (substance)
fumarates
aliskiren
amides
administration, oral
aliskiren
drug therapy, combination
antihypertensive agents
aliskiren
fumarates
amides
antihypertensive agents
renin
amides
fumarates
drug information
journal article

---
http://www.has-sante.fr/portail/jcms/c_886848/spondylarthrites-traitement-et-suivi-argumentaire
http://www.has-sante.fr/portail/jcms/c_800266/diagnostic-prise-en-charge-therapeutique-et-suivi-des-spondylarthrites
http://www.has-sante.fr/portail/jcms/c_886846/spondylarthrites-diagnostic-argumentaire
2008
false
false
Haute Autorité de santé
France
French
Adrenocortical steroid therapy
corticosteroid therapy
french abstract
spondylarthritis
diagnostic imaging
consumer health information
pregnancy
spondylarthritis
spondylarthritis
spondylarthritis
spondylarthritis
anti-inflammatory agents, non-steroidal
adrenal cortex hormones
tumor necrosis factor-alpha
arthritis, psoriatic
continuity of patient care
severity of illness index
clinical trials as topic
practice guideline
spondylarthritis
Tumor Necrosis Factor Inhibitors

---
http://www.has-sante.fr/portail/jcms/c_745452/evaluation-de-lautosurveillance-de-linr-chez-les-patients-adultes-traites-par-antivitamines-k
2008
France
French
antivitamins K
adult
vitamin K
hemorrhage
international normalized ratio
international normalized ratio
anticoagulants
monitoring, ambulatory
anticoagulants
antivitamins K
antivitamins K
vitamin k antagonists
evaluation studies
indenes
4-hydroxycoumarins

---
http://www.meddispar.fr/medicaments/3553024
2008
France
French
gonadotropin-releasing hormone
injections, subcutaneous
drug prescriptions
legislation, drug
self administration
ganirelix
hormone antagonists
gonadorelin
gonadotropin-releasing hormone
drug information

---
https://medicalforum.ch/fr/detail/doi/fms.2008.06442/
2008
false
Switzerland
French
Substance with renin inhibitor mechanism of action (substance)
renin
antihypertensive agents
journal article

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/3F/68/resume.md
2008
false
France
French
protein kinase C
protein kinase C
neoplastic processes
indoles
enzastaurin
aprinocarsen
staurosporine
phosphorothioate oligonucleotides
journal article

---
http://www.has-sante.fr/portail/jcms/c_682188/prise-en-charge-des-surdosages-des-situations-a-risque-hemorragique-et-des-accidents-hemorragiques-chez-les-patients-traites-par-antivitamines-k-en-ville-et-en-milieu-hospitalier
http://www.has-sante.fr/portail/jcms/c_682308/surdosage-en-avk-situations-a-risque-et-accidents-hemorragiques-document-destine-aux-medecins-generalistes
http://sfar.org/prise-en-charge-des-surdosages-en-antivitamines-k-des-situations-a-risque-hemorragique-et-des-accidents-hemorragiques-chez-les-patients-traites-par-antivitamines-k-en-ville-et-en-milieu-hospitalier/
http://sfar.org/?p=6761
2008
true
France
French
antivitamins K
anticoagulotherapy
general practitioners
vitamin K
drug overdose
hemorrhage
surgical procedures, operative
heparin
anticoagulants
anticoagulants
general practice
hemorrhage
patient care management
antivitamins K
antivitamins K
vitamin k antagonists
antivitamins K
practice guideline
indenes
4-hydroxycoumarins

---
https://www.minerva-ebp.be/fr/article/532
2008
false
minerva-ebm.be
Belgium
French
antivitamins K
aspirin
aspirin
treatment outcome
risk assessment
cardiovascular diseases
platelet aggregation inhibitors
vitamin K
anticoagulants
antivitamins K
drug therapy, combination
critical appraisal or critical reading
indenes
4-hydroxycoumarins

---
https://www.revmed.ch/RMS/2008/RMS-143/Anticoagulation-orale-au-long-cours-indications-et-problemes
2008
true
Switzerland
French
anticoagulotherapy
vitamin K
time
atrial fibrillation
anticoagulants
venous thromboembolism
heart valve diseases
heart valve prosthesis implantation
continuity of patient care
anticoagulants
administration, oral
medication adherence
vitamin k antagonists
journal article

---
http://www.has-sante.fr/portail/display.jsp?id=c_606483
http://www.has-sante.fr/portail/display.jsp?id=c_608766
2007
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
arthritis, rheumatoid
arthritis, rheumatoid
methotrexate
antirheumatic agents
glucocorticoids
tumor necrosis factor-alpha
anti-inflammatory agents, non-steroidal
phytotherapy
continuity of patient care
arthritis, rheumatoid
antibodies, monoclonal
immunoconjugates
interleukin 1 receptor antagonist protein
practice guideline
retraction of publication
Tumor Necrosis Factor Inhibitors

---
http://www.lecrat.eu/?s=Rimonabant+-+Acomplia%C2%AE
2007
France
French
pregnancy
breast feeding
receptors, cannabinoid
piperidines
pyrazoles
anti-obesity agents
rimonabant
piperidines
pyrazoles
drug information
Rimonabant

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2007/14479a-fra.php
2007
Canada
French
English
isoxazoles
isoxazoles
thiophenes
thiophenes
pregnancy
breast feeding
Chemical and Drug Induced Liver Injury
isoxazoles
thiophenes
hypertension, pulmonary
abnormalities, drug-induced
drug interactions
receptors, endothelin
isoxazoles
thiophenes
pharmacovigilance note
Contraindications, Drug

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F34F08H
2007
Belgium
French
tumor necrosis factor-alpha
receptors, tumor necrosis factor
arthritis, rheumatoid
antirheumatic agents
immunoglobulin G
antibodies, monoclonal
neoplasms
pharmacovigilance note
journal article
Tumor Necrosis Factor Inhibitors

---
https://www.jle.com/fr/revues/medecine/mca/e-docs/00/04/34/FB/article.md
2007
false
France
French
Substance with renin inhibitor mechanism of action (substance)
renin
antihypertensive agents
hypertension
amides
fumarates
renin-angiotensin system
angiotensin-converting enzyme inhibitors
angiotensin II type 1 receptor blockers
heart failure
kidney diseases
drug evaluation, preclinical
journal article
comparative study

---
http://revmed.ch/RMS/2007/RMS-94/32000
2007
false
Switzerland
French
Ranibizumab
Bevacizumab
aptamers, nucleotide
prognosis
pegaptanib
macular degeneration
vascular endothelial growth factor a
intravitreal injections
visual acuity
ocular vascular disorder agents
drug information
journal article
image

---
http://revmed.ch/RMS/2007/RMS-108/32229
2007
false
Switzerland
French
Omalizumab
anti-asthmatic agents
anti-allergic agents
asthma
asthma
receptors, ige
omalizumab
immunoglobulin e
journal article
drug information

---
http://revmed.ch/RMS/2007/RMS-113/32315
2007
true
Switzerland
French
corticosteroid therapy
mineralocorticoid receptor antagonists
spironolactone
heart failure
receptors, mineralocorticoid
cardiovascular diseases
aldosterone
cardiovascular diseases
signal transduction
receptors, mineralocorticoid
eplerenone
journal article
drug information
diuretics, potassium sparing
Eplerenone

---
http://revmed.ch/RMS/2007/RMS-124/32419
2007
true
Switzerland
French
antivitamins K
administration, oral
anticoagulants
vitamin K
polymorphism, single nucleotide
CYP2C9 protein, human
aryl hydrocarbon hydroxylases
mixed function oxygenases
pharmacogenetics
vitamin k antagonists
antivitamins K
mixed function oxygenases
aryl hydrocarbon hydroxylases
journal article
drug information
indenes
4-hydroxycoumarins

---
https://cadth.ca/media/compus/reports/compus_Scientific_Report_final_f.pdf
2007
Canada
French
proton pump inhibitors
Evidence-Based medicine
gastroesophageal reflux
dyspepsia
peptic ulcer
helicobacter pylori
helicobacter infections
canada
zollinger-ellison syndrome
proton pump inhibitors
guideline
drug evaluation
table

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/1D/61/resume.md?type=text.html
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/1D/61/article.md?type=text.html
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/1D/61/telecharger.md?code_langue=fr&format=application/pdf&titre=Version%20PDF
2006
France
French
antibodies, monoclonal
neoplasms
protein-tyrosine kinases
gastrointestinal stromal tumors
clinical trials as topic
antineoplastic agents
neoplastic processes
angiogenesis inhibitors
breast neoplasms
leukemia, myelogenous, chronic, bcr-abl positive
treatment outcome
Tyrosine Kinase Inhibitors
journal article
HER2 positive breast cancer

---
http://www.societechirorale.com/documents/Recommandations/recommandations_avk.pdf
2006
true
France
French
antivitamins K
anticoagulotherapy
vitamin K
anticoagulants
dentistry, operative
oral hemorrhage
risk assessment
oral surgical procedures
postoperative complications
hemostatic techniques
risk factors
international normalized ratio
antivitamins K
vitamin k antagonists
patient care management
practice guideline
indenes
4-hydroxycoumarins

---
https://rmlg.uliege.be/article/1440
2006
Belgium
French
proton pumps
time factors
gastroesophageal reflux
gastroesophageal reflux
costs and cost analysis
journal article

---
http://revmed.ch/RMS/2006/RMS-82/31727
2006
true
Switzerland
French
Adalimumab
Infliximab
tuberculosis
risk factors
tumor necrosis factor-alpha
leukopenia
arthritis, rheumatoid
Infections
Tumor necrosis factor alpha (TNF-α) inhibitors
immunoglobulin G
receptors, tumor necrosis factor
journal article
drug information
Tumor Necrosis Factor Inhibitors

---